Ma Huang

69 interactions 2 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Linezolid Injection

1 Major 68 Moderate

All (69) Major (1) Moderate (68)

Major

Ma Huang Linezolid Injection Zyvox Increased risk for excessive monoamine activity including headache, hyperpyrexia, arrhythmias, and hypertensive crisis Details

Moderate

Ma Huang Lisinopril Prinivil Explained Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Aspirin Acuprin® Increased risk of developing gastric mucosal lesions Details Ma Huang Aspirin Rectal Aspirin Increased risk of developing gastric mucosal lesions Details Ma Huang Atenolol Tenormin Explained Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Acebutolol Sectral® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Benazepril Lotensin Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Alfuzosin UroXatral Reduced effectiveness of alpha-1 adrenergic blockers Details Ma Huang Amlodipine Amvaz® Reduced hypotensive effect of calcium channel blockers Details Ma Huang Betaxolol Betoptic S Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Betaxolol Ophthalmic Betoptic® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Bisoprolol Zebeta® Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Bromfenac Ophthalmic Bromday® Increased risk of developing gastric mucosal lesions Details Ma Huang Candesartan Atacand Reduced effectiveness of angiotensin II receptor antagonists Details Ma Huang Captopril Capoten® Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Clonidine Transdermal Patch Catapres Increased blood pressure Details Ma Huang Dexamethasone Injection Decadron Decreased effectiveness of corticosteroids Details Ma Huang Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Decreased effectiveness of corticosteroids Details Ma Huang Diclofenac Ophthalmic Voltaren® Eye Drops Increased risk of developing gastric mucosal lesions Details Ma Huang Diclofenac Topical (Actinic Keratosis) Pennsaid Increased risk of developing gastric mucosal lesions Details Ma Huang Diclofenac Topical (Arthritis Pain) Pennsaid® Increased risk of developing gastric mucosal lesions Details Ma Huang Diclofenac Transdermal Patch Flector Increased risk of developing gastric mucosal lesions Details Ma Huang Doxazosin Cardura Reduced effectiveness of alpha-1 adrenergic blockers Details Ma Huang Enalapril Epaned Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Eprosartan Teveten® Reduced effectiveness of angiotensin II receptor antagonists Details Ma Huang Esmolol Brevibloc Reduced hypotensive effect of beta-adrenergic blockers Details Ma Huang Etodolac Lodine Increased risk of developing gastric mucosal lesions Details Ma Huang Felodipine Plendil® Reduced hypotensive effect of calcium channel blockers Details Ma Huang Fenoprofen Fenopron Increased risk of developing gastric mucosal lesions Details Ma Huang Fludrocortisone Acetate Florinef® Decreased effectiveness of corticosteroids Details Ma Huang Flurbiprofen Ansaid Increased risk of developing gastric mucosal lesions Details Ma Huang Flurbiprofen Ophthalmic Ocufen Increased risk of developing gastric mucosal lesions Details Ma Huang Fosinopril Monopril® Reduced effectiveness of angiotensin converting enzyme inhibitors Details Ma Huang Furosemide Injection Disal Reduced hypotensive effect of loop diuretics Details Ma Huang Guanabenz Wytensin® Increased blood pressure Details Ma Huang Guanfacine Intuniv Increased blood pressure Details Ma Huang Hydralazine Apresoline® Reduced hypotensive effect of hydrALAZINE Details Ma Huang Hydrocortisone Ala-Cort Decreased effectiveness of corticosteroids Details Ma Huang Hydrocortisone Injection A-Hydrocort® Decreased effectiveness of corticosteroids Details Ma Huang Ibuprofen Addaprin Increased risk of developing gastric mucosal lesions Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.